NCT Number: NCT07472582
The goal of this clinical trial is to investigate whether receiving chatbot-delivered stage-of-change-tailored online interventions is effective in reducing chemsex among men who have sex with men in Hong Kong. The main question it aims to answer is:
Does chatbot-delivered stage-of-changed online interventions reduce chemsex among men who have sex with men
Eligible participants will be randomly assigned to either the intervention or the control group. The control group will watch one online video introducing chemsex-related knowledge and harm reduction skills per week for 12 weeks. On top of the interventions received by the control group, participants in the intervention group will have access to a chatbot during the 12-week intervention period. The chatbot will deliver 12 weekly episodes of interventions tailored to once's current stage-of-change related to chemsex. The chatbot will also address questions related to chemsex during the intervention period.
Trial opening soon.
Get Notified18 year and older
Male
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will watch one online video introducing chemsex-related knowledge and harm reduction skills per week for 12 weeks. The chatbot will deliver 12 weekly episodes of interventions tailored to once's current stage-of-change related to chemsex. The chatbot will also address questions related to chemsex during the intervention period.
Participants will watch one online video introducing chemsex-related knowledge and harm reduction skills per week for 12 weeks.
Time frame: Baseline, after completion of the 12-week intervention (Month 3 or Week 12), and 3 months after completion of the 12-week intervention (Month 6)
Presence of chemsex will be measured by a validated questionnaire. Chemsex is defined as the use of any of the following psychoactive substances before or during sexual intercourse: ketamine, methamphetamine, cocaine, cannabis, ecstasy, Dormicum/Halcion/Erimin 5/nonprescription hypnotic drugs, heroin, cough suppressant (not for curing cough), amyl nitrite (popper), GHB/GBL, 5-methoxy-N, N-diisopropyltryptamine (Foxy), and mephedrone. Participants will be asked whether they had used any of the aforementioned psychoactive substances before or during sexual intercourse in the past 3 months at baseline, after completion of the 12-week intervention (Month 3 or Week 12), and 3 months after completion of the 12-week intervention (Month 6)
Contact information is provided by the study sponsor or research team.
Chinese University of Hong Kong
Other
A Chatbot to Reduce Chemsex and HIV-related Risk Behaviors Among Men Who Have Sex With Men: a Pilot Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07613307
Behavior, Behavior, Animal
Agra, India
View Trial DetailsNCT07376941
Behavior, Future Preferences
Jeddah, Saudi Arabia
View Trial DetailsNCT07371260
Behavior, Brain Diseases
Saint-Sébastien-de-Morsent, France
View Trial DetailsNCT07048301
Attitude, Behavior
View Trial Details